PMID: 9160851Apr 1, 1997Paper

Nicotine nasal spray and vapor inhaler: abuse liability assessment

Psychopharmacology
K J SchuhMaxine L Stitzer

Abstract

Acute subjective and physiological effects were examined to provide information relevant to abuse liability of new nicotine delivery systems. Subjects (n = 12) were overnight-deprived smokers who received 0, 4, 8 and 16 active puffs from nicotine-containing cigarettes (0.1 mg per puff), 0, 1, 2 or 4 nasal sprays (0.5 mg nicotine per spray) and 0, 30, 60 and 120 vapor inhalations (estimated 0.013 mg nicotine per inhalation) in a within-subject single blinded design. While smokers clearly liked cigarette puffs, there was much less evidence of liking produced by either nasal spray or vapor inhaler; only modest elevations on a measure of good drug effects were observed. The novel delivery products engendered unpleasant effects of burning throat and nose, watery eyes, runny nose, coughing and sneezing that might be expected to limit abuse liability. Nicotine plasma level and heart rate increase was dose-related for cigarettes and nasal spray but not for vapor inhaler, indicating limited nicotine delivery with the latter device. Overall, results are consistent with the conclusion that the nicotine nasal spray and vapor inhaler are of substantially lower abuse liability than cigarettes in experienced cigarette smokers receiving initia...Continue Reading

Citations

Apr 4, 2007·Psychopharmacology·Reuven Dar, Hanan Frenk
Mar 21, 2002·Clinics in Chest Medicine·Richard D Hurt, Jon O Ebbert
May 22, 2003·Drug and Alcohol Dependence·Roland R GriffithsNancy A Ator
Apr 25, 2000·Drug and Alcohol Dependence·T Eissenberg, R L Balster
Apr 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carol S MyersStephen J Heishman
Nov 22, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dorothy K HatsukamiScott Leischow
Jan 5, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·R D Hurt
Mar 2, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Brent CaldwellJulian Crane
Feb 24, 2006·Cardiology in Review·William H FrishmanTom Ky
May 1, 1997·Addiction·S J HeishmanJ K Ockene
Jun 5, 1998·Annual Review of Public Health·S ShiffmanJ E Henningfield
Mar 12, 2005·Annual Review of Public Health·K Michael Cummings, Andrew Hyland
Dec 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lawrence P CarterDorothy K Hatsukami
Oct 19, 2001·Clinical Pharmacokinetics·N G SchneiderE Lunell
Sep 25, 2002·CNS Drugs·Tammy Harris Sims, Michael C Fiore
Apr 8, 2006·CNS Drugs·Jennifer B McClure, Gary E Swan
Jun 30, 2007·American Journal of Public Health·Pearl BaderHarvey A Skinner
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Karl Fagerström
Nov 22, 2005·Expert Opinion on Drug Delivery·Saul ShiffmanJack E Henningfield
Sep 3, 2008·Pharmacology, Biochemistry, and Behavior·Saul ShiffmanTommy Chau
Feb 22, 2008·Clinical Pharmacology and Therapeutics·S L McCollE M Sellers
Mar 31, 2007·Preventive Cardiology·William H Frishman
May 8, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kevin P JensenMehmet Sofuoglu
Aug 1, 2006·Regulatory Toxicology and Pharmacology : RTP·Charlene H CallicuttJeffrey I Seeman
Jul 1, 1999·The Psychiatric Clinics of North America·W C Gamberino, M S Gold
May 3, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jeffrey I Seeman, Richard A Carchman
Mar 8, 2011·Drug and Alcohol Dependence·Jack E HenningfieldEllen Peters
Oct 22, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Thomas Eissenberg, Alan Shihadeh
Mar 5, 2003·Psychopharmacology·Elisabeth J HoutsmullerMaxine L Stitzer
Jun 6, 2009·Therapeutic Advances in Cardiovascular Disease·William H Frishman
Mar 1, 2005·Pharmacological Reviews·Janne HukkanenNeal L Benowitz
May 20, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Eric Y ChenWei-Chun Chin
Sep 10, 2021·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Andrea VansickelLeanne Campbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacology, Biochemistry, and Behavior
Elisabeth J HoutsmullerMaxine L Stitzer
The New England Journal of Medicine
L H Glantz, G J Annas
Journal of the National Cancer Institute
S Ulbrich
Australian and New Zealand Journal of Public Health
I Kerridge
© 2021 Meta ULC. All rights reserved